Barclays »

Hcw Biologics shares owned by Barclays

Quarter-by-quarter ownership of Hcw Biologics shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Hcw Biologics

Tip: Access up to 7 years of quarterly data

All positions including Hcw Biologics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hcw Biologics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $952 191 4.99

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Hcw Biologics

Jane Street
Citadel Advisors
Hrt Financial
Vanguard Fiduciary Trust
Tower Research Capital
Connective Capital Management
Vanguard Capital Management
Golden State Wealth Management
Barclays
Caitong International Asset Management
Advisor Group Holdings
UBS Group

View all funds holding Hcw Biologics